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Isabel M. Marrucho,[d] Lus Paulo N. Rebelo,[d] Cristina PrudÞncio,[b, e] Jo¼o Paulo Noronha,[a]
Zˇeljko Petrovski,*[a] and Lus C. Branco*[a]
Significant antiproliferative effects against various tumor cell
lines were observed with novel ampicillin salts as ionic liquids.
The combination of anionic ampicillin with appropriate ammo-
nium, imidazolium, phosphonium, and pyridinium cations
yielded active pharmaceutical ingredient ionic liquids (API-ILs)
that show potent antiproliferative activities against five differ-
ent human cancer cell lines: T47D (breast), PC3 (prostate),
HepG2 (liver), MG63 (osteosarcoma), and RKO (colon). Some
API-ILs showed IC50 values between 5 and 42 nm, activities that
stand in dramatic contrast to the negligible cytotoxic activity
level shown by the ampicillin sodium salt. Moreover, very low
cytotoxicity against two primary cell lines—skin (SF) and gingi-
val fibroblasts (GF)—indicates that the majority of these API-ILs
are nontoxic to normal human cell lines. The most promising
combination of antitumor activity and low toxicity toward
healthy cells was observed for the 1-hydroxyethyl-3-methylimi-
dazolium–ampicillin pair ([C2OHMIM][Amp]), making this the
most suitable lead API-IL for future studies.&Reword OK?&
&&First names added; please check. Please provide first
name for M. M. Santos.&& Researchers in the pharmaceutical
industry are currently facing a series of challenges in the dis-
covery of innovative and effective drugs and their subsequent
therapeutic applications.&&Rewording OK?&& Most active
pharmaceutical ingredients (APIs) are available in solid form,
a state that frequently suffers from polymorphic conversion,
low solubility, and a variety of other factors that affect the final
bioavailability. Various pharmaceutical salts, in sodium or po-
tassium form, have been developed to improve aqueous solu-
bility. Ionic liquids (ILs) are a peculiar class of organic salts with
melting points below 100 8C which have been the focus of in-
creasing interest in the scientific community and industry; the
large number of potential cation–anion combinations allows
a variety of tunable interactions and applications.[1] One of the
most promising applications of ILs is in the so-called third gen-
eration of ILs, that is, their arrangement with APIs to generate
API-ILs.[2–6] Successful buffer-controlled procedures for the
preparation of API-ILs containing the anion of ampicillin (a
well-known antibiotic) combined with members of four organ-
ic cation classes (ammonium, imidazolium, phosphonium, and
pyridinium) have been reported.[7–9] &&Rewording OK?&&
These API-IL combinations can be an innovative solution to
the polymorphic behavior of certain drugs, and can also im-
prove water solubility, permeability, and therefore bioavailabil-
ity. The appropriate arrangement of a biocompatible anion or
cation with a specific drug can be relevant in modifying the
corresponding biopharmaceutical drug classification system
(BCS)[2,4,10–12] as well as their drug formulation process.
The important question regarding the toxicity of the API
counter-ion in ILs has been the major cause behind the de-
layed entry of ILs into the wider biosciences field.[5, 13] &&Re-
wording OK?&& Toxicities toward microorganisms and eu-
karyotic cell cultures cover the entire range of biocidal poten-
cies, from rather inactive molecular solvents that are biocom-
patible, up to high concentrations in aqueous solutions for
pharmaceutical applications,[2, 4,12] and even as potential in vitro
anticancer agents.[8, 10] Antimicrobial activities against Escheri-
chia coli (susceptible and resistant), Klebsiella pneumoniae,
Staphylococcus aureus, and Enterococcus faecium have been re-
ported for some ampicillin organic salts in comparison with
sodium ampicillin ([Na][Amp]).[9,14] Consequently, the develop-
ment of novel anticancer drugs that are less toxic than current-
ly available chemotherapeutic treatments can also be pursued
with ionic liquids.[3, 4,12] &&Rewording OK?&& Herein we de-
scribe the antiproliferative effects of several previously synthe-
sized ampicillin ILs (Figure 1) against various tumor cell lines.
Table 1 summarizes the antitumor activities (IC50 and LD50) of
the ampicillin-anion-based ILs against two primary human cell
types: skin (SF) and gingival fibroblasts (GF). [Na][Amp] was
used as control, and as is evident from the data listed in
Table 1, it is one of the least toxic. The IC50 value was not de-
tected in the concentration range used against SF, and the IC50
value toward GF was 109.1 mm. In comparing the other synthe-
sized compounds with [Na][Amp], the most toxic toward the
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healthy human cell lines are [P6,6,6,14][Amp] and [C16Pyr][Amp]
(lowest IC50 values). Ammonium-based ILs [TEA][Amp] and
[Cholin][Amp] were found to be the least toxic, with imidazoli-
um-based ILs [EMIM][Amp] and [C2OHMIM][Amp] having IC50
values in between. These results are in agreement with pub-
lished work showing that higher hydrophobicity and increased
alkyl chain length lead to increased toxicity.[13, 15]
Table 2 summarizes the antitumor activities of the ampicillin-
based ILs against several human cancer cell lines: T47D
(breast), PC3 (prostate), HepG2 (liver), MG63 (osteosarcoma),
and RKO (colon). Figure 2 shows some representative experi-
mental data used to calculate these values listed. Among all
compounds tested, the 3-(2-hydroxyethyl)-1-methylimidazoli-
um–ampicillin salt ([C2OHMIM][Amp]) possesses the greatest
selectivity and antiproliferative activity against these five
cancer cell lines. Some lipophilic phase-transfer agents (coun-
ter-ions) can significantly assist the transfer of highly polar
molecules (different APIs) through prokaryotic and eukaryotic
membranes, thereby improving drug activity. However, we
have also shown that the lipophilicity of the counter-ion alone
does not necessarily solve all API problems, but can contribute
to the improvement of certain physicochemical properties
such as aqueous solubility and octanol–water partition coeffi-
cients (Kow).
[5] In this context, the outstanding antitumor activi-
ty of ampicillin salts can be explained by the stronger and
more stable cation–anion pairings brought about by the ex-
pected hydrogen bonding and p–p interactions, as well as
electrostatic interactions that can be established between the
ampicillin anion and certain organic cations. For example,
[C2OHMIM] can establish hydrogen bonding and p–p interac-
tions, as illustrated in Figure 1. As indicated in Figure 1 and
Table 2, the best results were observed for the cases of stron-
ger and more stable cation–anion interactions, where the ap-
propriate counter-ion acts as a more lipophilic drug carrier.
Ampicillin sodium salt ([Na][Amp]), which is a standard anti-
biotic in current use, only shows cytotoxic activity toward PC3
and RKO cell lines, with respective IC50 values greater than
0.597 and 2.406 mm. Moreover, its antiproliferative activity is
very weak toward the cell lines studied, with the exception of
HepG2. However, it is quite well tolerated by primary fibro-
blasts, namely GF. Markedly different antitumor results have
been observed by pairing distinct organic cations with ampicil-
lin. For instance, whereas [TEA][Amp] is highly cytotoxic
toward MG63 and T47D cells, [Cholin][Amp] was found to be
particularly selective for the RKO cell line. In addition, this API-
IL only shows significant antiproliferative behavior toward
MG63 cells. In contrast to other bulky cations, the high cyto-
toxic effect of [Cholin][Amp] toward MG63 cancer cells and
high selectivity &&away from&&Rewording OK?&& non-
cancerous cells can be partially attributed to its high water sol-
ubility and partition coefficient,[5] which facilitate the transport
of the xenobiotic (in this case, ampicillin) to the cytosol of
cancer cells. Moreover, this capacity is particularly enhanced in
these cells, as the [Cholin] cation is a nutrient.[3, 16] On the other
hand, [EMIM][Amp] is particularly selective against RKO, with
an IC50 value >0.269 mm. Considering the previously reported
physicochemical properties of these compounds,[5] the en-
hanced cytotoxic activity toward particular cancer cell lines as
well as low toxicity against primary fibroblasts can be related
to the greater lipophilic character of these cations than the
sodium analogue.
[C2OHMIM][Amp] was found to be a very potent antitumor
agent against all cancer cell lines studied, with IC50 and LD50
values in the ranges of 0.146–0.738 mm and 0.297–4.197 mm, re-
spectively. A similar observation was made for the [P6,6,6,14]
[Amp] IL; however, it is 90- to 173-fold more toxic toward pri-
mary fibroblasts. This finding is not surprising, as the very high
toxicity of compounds with this cation toward other cell lines
was described previously, with similar IC50 and LD50 values.
[17,18]
[C16Pyr][Amp], which showed IC50 values in the low nanomolar
range toward MG63 and T47D cells, was also shown to be
Figure 1. Structures of ampicillin salts and their possible cation–anion inter-
actions. Details of their synthesis are available in the Supporting Informa-
tion.
Table 1. Antitumor activities of the prepared ILs against two primary
human cell types.
Compd Cell line
SF[b] GF[c]
[TEA][Amp]
IC50 [mm] ND
[d] ND[d]
LD50 [mm] ND
[d] >58.040
[P6,6,6,14][Amp]
IC50 [mm] >0.249 >0.173
LD50 [mm] >0.249 >0.176
[C16Pyr][Amp]
IC50 [mm] >0.032 >0.012
LD50 [mm] >0.815 45.5100.131
[Cholin][Amp]
IC50 [mm] 48.4800.571 ND[d]
LD50 [mm] 49.7900.368 ND[d]
[EMIM][Amp]
IC50 [mm] >6.366 >0.853
LD50 [mm] >6.366 >9.357
[C2OHMIM][Amp]
IC50 [mm] >5.084 >0.462
LD50 [mm] >22.600 30.4700.428
[Na][Amp][a]
IC50 [mm] ND
[d] >109.100
LD50 [mm] >8.104 >109.100
[a] [Na][Amp] was used as a control. [b] Skin fibroblasts. [c] Gingival fibro-
blasts. [d] Not detected in the concentration range used. [Amp]=ampicil-
lin anion, [TEA]= tetraethylammonium, [P6,6,6,14]= trihexyltetradecylphos-
phonium, [C16Pyr]=cetylpyridinium, [Cholin]=choline, [EMIM]=1-ethyl-3-
methylimidazolium, [C2OHMIM]=1-hydroxyethyl-3-methylimidazolium.
Data were obtained from three independent experiments, and each assay
was performed in three replicates; for all experiments the associated
errors (SD) did not exceed 5%.
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fairly toxic toward fibroblasts, namely SF. This observation is in
line with that previously reported for the [C16Pyr] cation,
[19,20]
despite its frequent application in pharmaceutical formulations.
The particularly high toxicity toward cancerous and/or normal
cells shown by these three API-ILs is probably related to their
high amphiphilic character relative to the analogous sodium
salt ;[5] this promotes cell membrane permeation and conse-
quently their efficiency.
Notably, choline salts with acetate, propanoate, butanoate,
hexanoate, and pivalate anions showed IC50 values >10 mm
toward MCF-7 lung cancer cells which increase with the length
of the carbon chain.[21] Usually, other ionic liquids containing
quaternary ammonium cations are not cytotoxic toward cancer
cell lines.[8] As previously reported by Malhotra et al. ,[9] methyli-
midazolium-based ionic liquids only show cytotoxic activity if
the alkyl side chain contains more than 11 methylene units.&
&Rewording OK?&&
In conclusion, the combination of ampicillin with organic
cations in place of sodium has yielded novel ionic liquids that
show low IC50 and LD50 values against five different cancer cell
lines: T47D (breast), PC3 (prostate), HepG2 (liver), MG63 (osteo-
sarcoma), and RKO (colon). Furthermore, very low toxicity
Figure 2. Experimental IC50 data for the most representative compounds toward A) RKO, B) PC3, C) HepG2, and D) T47D cell lines. Data are the mean SD de-
termined from three separate experiments; each assay was performed in three replicates.&&Caption OK?&&
Table 2. Antitumor activities of the prepared ILs against several human cancer cell lines.
Compd Cell line[b]
MG63 HepG2 T47D PC3 RKO
[TEA][Amp]
IC50 [mm] >0.030 ND
[d] >0.042 >35.650 >56.700
LD50 [mm] 1.3680.020 0.0950.008 >43.990 >58.920 68.3700.511
[P6,6,6,14]
[Amp]
IC50 [mm] 0.3120.019 >0.322 >0.264 >0.354 >0.180
LD50 [mm] >0.312 >0.322 >4.970 9.3350.179 >11.860
[C16Pyr]
[Amp]
IC50 [mm] >0.011 ND
[d] >0.005 132.7003.593 >0.226
LD50 [mm] >183.200 ND
[d] ND[d] >132.700 59.1700.095
[Cholin]
[Amp]
IC50 [mm] >0.017 >1.619 >110.900 >0.982 ND
[d]
LD50 [mm] >0.031 >5.765 >110.900 17.1600.514 >0.707
[EMIM]
[Amp]
IC50 [mm] >1.122 >24.270 ND
[d] >29.990 >0.269
LD50 [mm] >1.122 >24.270 32.3700.121 >31.020 >209.700
[C2OHMIM]
[Amp]
IC50 [mm] >0.738 >0.319 >0.146 >0.297 >0.359
LD50 [mm] >1.240 >0.4040 >0.498 >0.297 >0.362
[Na]
[Amp][a]
IC50 [mm] ND
[d] ND[d] ND[d] >0.597 >2.406
LD50 [mm] >506.600 ND
[d] >47.790 560.9000.515 >920.800
[a] [Na][Amp] was used as a control. [b] Cancer cell lines: T47D (breast), PC3 (prostate), HepG2 (liver), MG63 (osteosarcoma), and RKO (colon). [d] Not de-
tected in the concentration range used. [Amp]=ampicillin anion, [TEA]= tetraethylammonium, [P6,6,6,14]= trihexyltetradecylphosphonium, [C16Pyr]=cetyl-
pyridinium, [Cholin]=choline, [EMIM]=1-ethyl-3-methylimidazolium, [C2OHMIM]=1-hydroxyethyl-3-methylimidazolium. Data were obtained from three in-
dependent experiments, and each assay was performed in three replicates; for all experiments the associated errors (SD) did not exceed 8%.
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against two primary cell lines—skin (SF) and gingival fibro-
blasts (GF)—indicates that the majority of these compounds
are nontoxic to certain healthy human cells. Outstanding cyto-
toxic and antiproliferative activities against several tumor cell
lines, with IC50 and LD50 values in the low micromolar range,
associated with low activity against primary fibroblasts was ob-
served for [C2OHMIM][Amp]. On the other hand, [TEA][Amp],
[Cholin][Amp], and [EMIM][Amp] showed IC50 values in the
nanomolar or low micromolar range against some of the
cancer cell lines tested, as well as very low toxicity toward
normal cells. These data make these API-ILs the most promis-
ing lead compounds for future in vivo studies. Importantly, se-
lection of the appropriate counter-ions can explain these anti-
tumor activities due to the stronger and more stable cation–
anion interactions relative to the sodium analogue. Therefore,
suitable organic cations can establish efficient ion pairs, acting
as lipophilic drug carriers as well as improving water solubility,
permeability, and bioavailability of the final pharmaceutical
salts.
Experimental Section
All compounds were prepared by using an optimized and sustaina-
ble method described in the Supporting Information.[5] The synthe-
sized compounds were then evaluated for their antiproliferative ac-
tivity against the following human cancer cell lines: T47D (ductal
breast epithelial tumor), PC3 (prostate cancer), HepG2 (hepatocel-
lular liver carcinoma), MG63 (osteosarcoma), and RKO (colon
cancer). Two primary human cell types, skin and gingival fibro-
blasts (SF and GF, respectively), were also tested. Cells were main-
tained in a-minimal essential medium (a-MEM) containing 10%
fetal bovine serum, 100 IUmL1 &&Units OK?&& penicillin,
2.5 mgmL1 streptomycin, 2.5 mgmL1 amphotericin B, and
50 mgmL1 ascorbic acid. At ~70–80% confluence, cells were enzy-
matically detached with 0.05% trypsin and 0.5 mm EDTA and
seeded at 104 cells cm2. After an attachment period of 24 h, the
culture medium was renewed and supplemented with various con-
centrations (0.005–500 mm) of the ampicillin-based ILs. Cell cul-
tures were maintained in a 5% CO2 humidified atmosphere at
37 8C. Cellular viability/proliferation was assessed by MTT assay at
days 1, 3, and 5 of the culture. This assay is based on the reduction
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to
a purple formazan product by viable cells. Briefly, cultured cells
were incubated at 37 8C with MTT (0.5 mgmL1) for 4 h. The cul-
ture medium was then removed; the stained product was dis-
solved in DMSO, and absorbance was measured at l=550 nm in
an ELISA plate reader. Results were expressed as absorbance per
square centimeter (Acm2).[22] Half-maximal inhibitory concentra-
tion (IC50) and median lethal dose (LD50) values were obtained by
nonlinear regression analysis of concentration–effect curves, using
GraphPad Prism software (&&version?&& ).[23] The definition of
IC50 is given by Sebaugh
[24]&&Ref. [24] (formerly ref. [18]) is not Se-
baugh; should this be [16] (formerly [19])? If so, then [24] will lack
a citation in the text. Please check, and see comment below as well.
&& as “the response corresponding to the 50% control (the
mean of the 0% and 100% assay controls)” and is used to measure
the efficacy of a compound in inhibiting any biochemical or bio-
logical function. LD50 is the median lethal dose and is the amount
of material that causes the death of 50% of a population.[16] &
&Please note: references were renumbered to reflect the order in
which they appear in the text. Ref. [19] was changed to [16], [20!
17], [21!18], [22!19], [23!20], [24!21] ; likewise, [old 16!22],
[old 17!23], [old 18!24].&&
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Antitumor Activity of Ionic Liquids
Based on Ampicillin
That’s quite ionic: Antiproliferative ef-
fects against various tumor cell lines
were observed with novel ampicillin
salts as ionic liquids. Some of these salts
possesses highly discriminating and
strong antiproliferative activity against
five different human cancer cell lines, in
particular T47D (breast), PC3 (prostate),
HepG2 (liver), MG63 (osteosarcoma),
and RKO (colon, shown here).
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